Is Ultragenyx Pharmaceutical Inc. (RARE) a Buy, Sell, or Hold?
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$31.5006 USD
-$0.53 (-1.65%)
- Volume
- 331.95K
- Average Volume
- 2.2M
- Market Capitalization
- $3.1B
- P/E Ratio
- -5.16
- Dividend Yield
- 0.00%
- Price Target
- $43.00
- Year High
- $39.89
- Year Low
- $18.29
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.02
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
37
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
28
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 156.4K
RARE Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
RARE Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Horn Howard | officer: Chief Financial Officer | 2026-07-01 | S-Sale | 33.13 | 2026-07-06 |
| Sanders Corazon (Corsee) D. | director | 2026-06-15 | S-Sale | 25.05 | 2026-06-15 |
| Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 2026-06-15 | S-Sale | 24.62 | 2026-06-15 |
| Horn Howard | officer: Chief Financial Officer | 2026-06-01 | S-Sale | 23.77 | 2026-06-01 |
| Fust Matthew K | director | 2026-05-14 | A-Award | 0 | 2026-05-18 |
| Fust Matthew K | director | 2026-05-14 | A-Award | 25.8 | 2026-05-18 |
| SULIMAN SHEHNAAZ | director | 2026-05-14 | A-Award | 0 | 2026-05-18 |
| SULIMAN SHEHNAAZ | director | 2026-05-18 | S-Sale | 25.12 | 2026-05-18 |
| SULIMAN SHEHNAAZ | director | 2026-05-14 | A-Award | 25.8 | 2026-05-18 |
| Ray Amrit | director | 2026-05-14 | A-Award | 0 | 2026-05-18 |
| Ray Amrit | director | 2026-05-14 | A-Award | 25.8 | 2026-05-18 |
| Sanders Corazon (Corsee) D. | director | 2026-05-14 | A-Award | 0 | 2026-05-18 |
| Sanders Corazon (Corsee) D. | director | 2026-05-14 | A-Award | 25.8 | 2026-05-18 |
| NARACHI MICHAEL | director | 2026-05-14 | A-Award | 0 | 2026-05-18 |
| NARACHI MICHAEL | director | 2026-05-14 | A-Award | 25.8 | 2026-05-18 |
| WELCH DANIEL G | director | 2026-05-14 | A-Award | 0 | 2026-05-18 |
| WELCH DANIEL G | director | 2026-05-14 | A-Award | 25.8 | 2026-05-18 |
| Dunsire Deborah | director | 2026-05-14 | A-Award | 0 | 2026-05-18 |
| Dunsire Deborah | director | 2026-05-14 | A-Award | 25.8 | 2026-05-18 |
| Crombez Eric | officer: EVP and Chief Medical Officer | 2026-05-05 | S-Sale | 24.96 | 2026-05-06 |
| Horn Howard | officer: Chief Financial Officer | 2026-05-01 | S-Sale | 24.9 | 2026-05-04 |
| Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 2026-04-22 | A-Award | 0 | 2026-04-24 |
| Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 2026-04-22 | A-Award | 24.61 | 2026-04-24 |
| KAKKIS EMIL D | director, officer: President & CEO | 2026-04-16 | A-Award | 0 | 2026-04-20 |
| KAKKIS EMIL D | director, officer: President & CEO | 2026-04-16 | A-Award | 24.52 | 2026-04-20 |
| Huang Dennis Karl | officer: See Remarks | 2026-04-16 | A-Award | 0 | 2026-04-20 |
| Huang Dennis Karl | officer: See Remarks | 2026-04-16 | A-Award | 24.52 | 2026-04-20 |
| Pinion John Richard | officer: See Remarks | 2026-04-16 | A-Award | 0 | 2026-04-20 |
| Pinion John Richard | officer: See Remarks | 2026-04-16 | A-Award | 24.52 | 2026-04-20 |
| Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 2026-04-16 | A-Award | 0 | 2026-04-20 |
| Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 2026-04-16 | A-Award | 24.52 | 2026-04-20 |
| Harris Erik | officer: EVP & Chief Commercial Officer | 2026-04-16 | A-Award | 0 | 2026-04-20 |
| Harris Erik | officer: EVP & Chief Commercial Officer | 2026-04-16 | A-Award | 24.52 | 2026-04-20 |
| Crombez Eric | officer: EVP and Chief Medical Officer | 2026-04-16 | A-Award | 0 | 2026-04-20 |
| Crombez Eric | officer: EVP and Chief Medical Officer | 2026-04-16 | A-Award | 24.52 | 2026-04-20 |
| Horn Howard | officer: Chief Financial Officer | 2026-04-16 | A-Award | 0 | 2026-04-20 |
| Horn Howard | officer: Chief Financial Officer | 2026-04-16 | A-Award | 24.52 | 2026-04-20 |
| Horn Howard | officer: Chief Financial Officer | 2026-04-01 | S-Sale | 20.97 | 2026-04-02 |
| Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 2026-03-06 | S-Sale | 21.4 | 2026-03-10 |
| Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 2026-03-10 | S-Sale | 22.67 | 2026-03-10 |
| Pinion John Richard | officer: See Remarks | 2026-03-01 | A-Award | 0 | 2026-03-03 |
| Pinion John Richard | officer: See Remarks | 2026-03-02 | S-Sale | 22.8 | 2026-03-03 |
| Harris Erik | officer: EVP & Chief Commercial Officer | 2026-03-01 | A-Award | 0 | 2026-03-03 |
| Harris Erik | officer: EVP & Chief Commercial Officer | 2026-03-02 | S-Sale | 22.8 | 2026-03-03 |
| KAKKIS EMIL D | director, officer: President & CEO | 2026-03-01 | A-Award | 0 | 2026-03-03 |
| KAKKIS EMIL D | director, officer: President & CEO | 2026-03-02 | S-Sale | 22.8 | 2026-03-03 |
| Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 2026-03-01 | A-Award | 0 | 2026-03-03 |
| Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 2026-03-02 | S-Sale | 22.8 | 2026-03-03 |
| Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 2026-03-02 | F-InKind | 23.39 | 2026-03-03 |
| Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 2026-03-02 | S-Sale | 22.8 | 2026-03-03 |
| Horn Howard | officer: Chief Financial Officer | 2026-03-01 | A-Award | 0 | 2026-03-03 |
| Horn Howard | officer: Chief Financial Officer | 2026-03-02 | S-Sale | 22.8 | 2026-03-03 |
| Horn Howard | officer: Chief Financial Officer | 2026-03-02 | S-Sale | 22.54 | 2026-03-03 |
| Horn Howard | officer: Chief Financial Officer | 2026-03-03 | S-Sale | 22.4 | 2026-03-03 |
| Crombez Eric | officer: EVP and Chief Medical Officer | 2026-03-01 | A-Award | 0 | 2026-03-03 |
| Crombez Eric | officer: EVP and Chief Medical Officer | 2026-03-02 | S-Sale | 22.8 | 2026-03-03 |
| Huang Dennis Karl | officer: See Remarks | 2026-03-01 | A-Award | 0 | 2026-03-03 |
| Huang Dennis Karl | officer: See Remarks | 2026-03-02 | F-InKind | 23.39 | 2026-03-03 |
| Horn Howard | officer: Chief Financial Officer | 2026-02-02 | S-Sale | 23.56 | 2026-02-03 |
| Horn Howard | officer: Chief Financial Officer | 2026-01-02 | S-Sale | 22.84 | 2026-01-05 |
| Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 2025-12-29 | S-Sale | 34.38 | 2025-12-30 |
| Horn Howard | officer: Chief Financial Officer | 2025-12-10 | S-Sale | 36.38 | 2025-12-11 |
| Horn Howard | officer: Chief Financial Officer | 2025-10-13 | S-Sale | 31.51 | 2025-10-14 |
| Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 2025-09-18 | S-Sale | 29.17 | 2025-09-19 |
| Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 2025-09-12 | S-Sale | 31.17 | 2025-09-12 |
| Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | 2025-09-05 | S-Sale | 31.39 | 2025-09-08 |
| Sanders Corazon (Corsee) D. | director | 2025-06-20 | S-Sale | 37.39 | 2025-06-23 |
| SULIMAN SHEHNAAZ | director | 2025-05-15 | A-Award | 0 | 2025-05-19 |
| SULIMAN SHEHNAAZ | director | 2025-05-15 | A-Award | 34.84 | 2025-05-19 |
| WELCH DANIEL G | director | 2025-05-15 | A-Award | 0 | 2025-05-19 |
| WELCH DANIEL G | director | 2025-05-15 | A-Award | 34.84 | 2025-05-19 |
| Sanders Corazon (Corsee) D. | director | 2025-05-15 | A-Award | 0 | 2025-05-19 |
| Sanders Corazon (Corsee) D. | director | 2025-05-15 | A-Award | 34.84 | 2025-05-19 |
| NARACHI MICHAEL | director | 2025-05-15 | A-Award | 0 | 2025-05-19 |
| NARACHI MICHAEL | director | 2025-05-15 | A-Award | 34.84 | 2025-05-19 |
| Fust Matthew K | director | 2025-05-15 | A-Award | 0 | 2025-05-19 |
| Fust Matthew K | director | 2025-05-15 | A-Award | 34.84 | 2025-05-19 |
| Dunsire Deborah | director | 2025-05-15 | A-Award | 0 | 2025-05-19 |
| Dunsire Deborah | director | 2025-05-15 | A-Award | 34.84 | 2025-05-19 |
| Ray Amrit | director | 2025-05-15 | A-Award | 0 | 2025-05-19 |
| Ray Amrit | director | 2025-05-15 | A-Award | 34.84 | 2025-05-19 |
| Crombez Eric | officer: EVP and Chief Medical Officer | 2025-04-21 | S-Sale | 35.11 | 2025-05-05 |
| Crombez Eric | officer: EVP and Chief Medical Officer | 2025-05-05 | S-Sale | 39.24 | 2025-05-05 |
| Horn Howard | officer: Chief Financial Officer | 2025-03-06 | S-Sale | 40.4 | 2025-03-10 |
| Kassberg Thomas Richard | officer: CBO & EVP | 2025-03-01 | A-Award | 0 | 2025-03-04 |
| Kassberg Thomas Richard | officer: CBO & EVP | 2025-03-03 | S-Sale | 42.1 | 2025-03-04 |
| Kassberg Thomas Richard | officer: CBO & EVP | 2025-03-03 | F-InKind | 42.92 | 2025-03-04 |
| Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 2025-03-01 | A-Award | 0 | 2025-03-04 |
| Parschauer Karah Herdman | officer: EVP and Chief Legal Officer | 2025-03-03 | S-Sale | 42.1 | 2025-03-04 |
| Crombez Eric | officer: EVP and Chief Medical Officer | 2025-03-01 | A-Award | 0 | 2025-03-04 |
| Crombez Eric | officer: EVP and Chief Medical Officer | 2025-03-03 | S-Sale | 42.1 | 2025-03-04 |
| Crombez Eric | officer: EVP and Chief Medical Officer | 2025-03-01 | A-Award | 0 | 2025-03-04 |
| Crombez Eric | officer: EVP and Chief Medical Officer | 2025-03-01 | A-Award | 42.92 | 2025-03-04 |
| Pinion John Richard | officer: See Remarks | 2025-03-01 | A-Award | 0 | 2025-03-04 |
| Pinion John Richard | officer: See Remarks | 2025-03-03 | F-InKind | 42.92 | 2025-03-04 |
| Pinion John Richard | officer: See Remarks | 2025-03-03 | S-Sale | 42.1 | 2025-03-04 |
| Pinion John Richard | officer: See Remarks | 2025-03-01 | A-Award | 0 | 2025-03-04 |
| Pinion John Richard | officer: See Remarks | 2025-03-01 | A-Award | 42.92 | 2025-03-04 |
| KAKKIS EMIL D | director, officer: President & CEO | 2025-02-28 | S-Sale | 42.48 | 2025-03-04 |
| KAKKIS EMIL D | director, officer: President & CEO | 2025-03-01 | A-Award | 0 | 2025-03-04 |